ArticleFrontiers in oncology2025
Case Report: Mucoepidermoid carcinoma of the lung, a challenging diagnosis of an unusual case.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer comprises several types of tumors, with the most common subtypes being adenocarcinoma and squamous cell carcinoma. Mucoepidermoid carcinoma of the lung is an extremely rare entity, whose diagnosis and treatment are challenging. Case presentation: We reported a 55-year-old woman who was diagnosed in the context of a respiratory disease with a mucoepidermoid carcinoma of the lung. The diagnosis was not easy due to the difficulty in obtaining a correct tissue sample to study. After discussing the case in a multidisciplinary tumor board, the patient underwent surgery with the exceptional diagnosis of a low-grade mucoepidermoid carcinoma of the lung. Since then, the patient has been on follow-up, with no evidence of disease. Conclusions: There are some subtypes of lung cancer with very different behavior from the classical ones. For example, mucoepidermoid carcinomas of the lung have an exceptional survival with surgery, without needing further treatment, when they are classified as low-grade. This case report underscores the importance of an appropriate diagnosis based on the work of multidisciplinary tumor boards, even when there are difficulties in obtaining a tissue sample, to offer to the patients the best opportunities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.